Literature DB >> 9295173

Mast cell specific proteases in rat brain: changes in rats with experimental allergic encephalomyelitis.

A Rouleau1, V Dimitriadou, M D Trung Tuong, G F Newlands, H R Miller, J C Schwartz, M Garbarg.   

Abstract

Mast cell populations were identified within brain parenchyma by their specific proteases, using antibodies for immunohistochemistry and ELISAs, and riboprobes were developed for in situ hybridisation. Connective tissue mast cells expressing rat mast cell protease I (RMCPI) mRNA and immunoreactivity were observed in thalamus and showed no degranulation at 3, 8 and 13 days after induction of experimental allergic encephalomyelitis (EAE). Mucosal-like mast cells were clearly demonstrated in control rats by measuring RMCPII and by visualising cells expressing RMCPII mRNA and immunoreactivity. At day 13, but not 3 and 8 post immunisation, the number of RMCPII-expressing cells markedly increased in the EAE-induced group, mainly within brainstem and spinal cord close to inflammed blood vessels. The markers of histaminergic neurons were marginally affected 13 days after immunisation and the increase of [3H] histamine synthesis elicited by the H3-receptor antagonist, thioperamide, was not modified in any region of the brain. It is concluded that the cerebral RMCPII-expressing mast cells could play a role during EAE.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9295173     DOI: 10.1007/BF01277659

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  67 in total

Review 1.  Microenvironmental factors that influence mast cell phenotype and function.

Authors:  M Swieter; S E Mergenhagen; R P Siraganian
Journal:  Proc Soc Exp Biol Med       Date:  1992-01

Review 2.  Cytokine production by mast cells and basophils.

Authors:  S J Galli; J R Gordon; B K Wershil
Journal:  Curr Opin Immunol       Date:  1991-12       Impact factor: 7.486

3.  Changes of neurotransmitter systems in chronic relapsing experimental allergic encephalomyelitis in rat brain and spinal cord.

Authors:  W Krenger; C G Honegger; C Feurer; S Cammisuli
Journal:  J Neurochem       Date:  1986-10       Impact factor: 5.372

4.  Experimental autoimmune demyelination. Chronic relapsing models and their therapeutic implications for multiple sclerosis.

Authors:  C S Raine; U Traugott
Journal:  Ann N Y Acad Sci       Date:  1984       Impact factor: 5.691

5.  Identification of IgE-positive cells and mast cells in frozen sections of multiple sclerosis brains.

Authors:  R Toms; H L Weiner; D Johnson
Journal:  J Neuroimmunol       Date:  1990-12       Impact factor: 3.478

6.  Effects of histamine H3-receptor ligands on various biochemical indices of histaminergic neuron activity in rat brain.

Authors:  M Garbarg; M D Tuong; C Gros; J C Schwartz
Journal:  Eur J Pharmacol       Date:  1989-05-02       Impact factor: 4.432

7.  Rat cerebral mast cells undergo phenotypic changes during development.

Authors:  V Dimitriadou; A Rouleau; M D Tuong; X Ligneau; G F Newlands; H R Miller; J C Schwartz; M Garbarg
Journal:  Brain Res Dev Brain Res       Date:  1996-11-22

8.  Mast cells synthesize, store, and release nerve growth factor.

Authors:  A Leon; A Buriani; R Dal Toso; M Fabris; S Romanello; L Aloe; R Levi-Montalcini
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

9.  Functional relationship between mast cells and C-sensitive nerve fibres evidenced by histamine H3-receptor modulation in rat lung and spleen.

Authors:  V Dimitriadou; A Rouleau; M Dam Trung Tuong; G J Newlands; H R Miller; G Luffau; J C Schwartz; M Garbarg
Journal:  Clin Sci (Lond)       Date:  1994-08       Impact factor: 6.124

10.  Histamine and histamine-N-methyltransferase in the CSF of patients with multiple sclerosis.

Authors:  L Tuomisto; H Kilpeläinen; P Riekkinen
Journal:  Agents Actions       Date:  1983-04
View more
  3 in total

1.  c-kit plays a critical role in induction of intravenous tolerance in experimental autoimmune encephalomyelitis.

Authors:  Farinaz Safavi; Hongmei Li; Patricia Gonnella; Elisabeth Rose Mari; Javad Rasouli; Guang Xian Zhang; Abdolmohamad Rostami
Journal:  Immunol Res       Date:  2015-03       Impact factor: 2.829

2.  Vasoactive intestinal peptide (VIP) treatment of Parkinsonian rats increases thalamic gamma-aminobutyric acid (GABA) levels and alters the release of nerve growth factor (NGF) by mast cells.

Authors:  Orhan Tansel Korkmaz; Neşe Tunçel; Muzaffer Tunçel; Elif Mine Oncü; Varol Sahintürk; Mustafa Celik
Journal:  J Mol Neurosci       Date:  2009-12-02       Impact factor: 3.444

Review 3.  Mast cells and neuroinflammation.

Authors:  Hongquan Dong; Xiang Zhang; Yanning Qian
Journal:  Med Sci Monit Basic Res       Date:  2014-12-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.